Inhibition of human cytomegalovirus by combined acyclovir and vidarabine.
The inhibition of human cytomegalovirus (HCMV) isolates by acyclovir (ACV) and vidarabine (ara-A) was assessed by using an infectious-center plaque-reduction assay. When fixed concentrations of 4.5 micrograms of ACV and 250 ng of ara-A per ml were compared singly and in combination, the viral inhibi...
保存先:
| 出版年: | Antimicrob Agents Chemother |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Microbiology (ASM)
1985
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180103/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2988432/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.600 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|